Literature DB >> 9681522

Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.

A A Evans1, A P O'Connell, J C Pugh, W S Mason, F M Shen, G C Chen, W Y Lin, A Dia, S M'Boup, B Dramé, W T London.   

Abstract

The risk of hepatocellular carcinoma (HCC) varies significantly among hepatitis B virus (HBV) carriers from different geographic regions. We compared serological markers of HBV infection in adult male carriers from Haimen City, China and Senegal, West Africa, where the prevalence of chronic infection is similar. HCC mortality among HBV carriers is much higher in Haimen City than it is in Senegal (age-standardized rate, 878 versus 68 per l0(5) person-years). A dramatic difference was observed when HBV DNA levels in serum were assessed among carriers by Southern blot. In the Senegalese group (n = 289), 14.5% were HBV DNA positive by Southern blot in their 20s, and this percentage declined in each subsequent decade of age to 3.3, 2.9, and 0% thereafter. In the Chinese group (n = 285), a higher prevalence of HBV DNA positivity and a less consistent reduction were seen; 29.4% were positive in their 20s, and 30.2, 23.6, and 20.6%, respectively, were positive in each subsequent decade of age. Among 102 male Asian-American HBV carriers, the prevalence of HBV DNA positivity was intermediate between the Chinese and Senegalese populations (36.8, 10.7, 3.0, and 4.6% in each subsequent decade of age). Viral titers were similar among those who were HBV DNA positive in all three populations [median value, 10(7) virions/ml (range, 10(6)-10(9) virions/ml)]. The presence of HBV DNA in serum was positively associated with serum glutathione S-transferase, a marker of liver damage. These findings suggest that the more prolonged maintenance of productive virus infection in the Chinese carriers compared with the Senegalese carriers may explain their higher risk of HCC. This profound difference in the natural history of chronic infection may be due to earlier age of infection in China or to as yet unknown environmental or genetic factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681522

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  16 in total

1.  Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.

Authors:  Fat-Moon Suk; Min-Hui Lin; Margaret Newman; Shann Pan; Sheng-Hsuan Chen; Jean-Dean Liu; Chiaho Shih
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

Review 3.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

5.  Unrevealing the natural course of the so-called "inactive HBsAg or HBV carrier state".

Authors:  Stephanos J Hadziyannis
Journal:  Hepatol Int       Date:  2007-06       Impact factor: 6.047

Review 6.  Hepatocellular carcinoma: A global view.

Authors:  Ju Dong Yang; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-07-13       Impact factor: 46.802

7.  Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach.

Authors:  Hui Nie; Alison A Evans; W Thomas London; Timothy M Block; Xiangdong David Ren
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

8.  Quantification of complex precore mutations of hepatitis B virus by SimpleProbe real time PCR and dual melting analysis.

Authors:  Hui Nie; Alison A Evans; W Thomas London; Timothy M Block; Xiangdong David Ren
Journal:  J Clin Virol       Date:  2011-06-12       Impact factor: 3.168

9.  Immune selection during chronic hepadnavirus infection.

Authors:  William S Mason; Sam Litwin; Allison R Jilbert
Journal:  Hepatol Int       Date:  2007-12-14       Impact factor: 6.047

10.  Etiology of hepatocellular carcinoma in West Africa, a case-control study.

Authors:  Antoine Jaquet; Boris Tchounga; Aristophane Tanon; Aklesso Bagny; Didier K Ekouevi; Hamar A Traore; Annie J Sasco; Moussa Maiga; François Dabis
Journal:  Int J Cancer       Date:  2018-04-10       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.